These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer. Vaizoglu F, Yuce K, Salman MC, Basaran D, Calis P, Ozgul N, Usubutun A. Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931 [Abstract] [Full Text] [Related]
3. Risk factors for paraaortic lymph node metastasis in endometrial cancer. Sari ME, Yalcin İ, Sahin H, Meydanli MM, Gungor T. Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533 [Abstract] [Full Text] [Related]
4. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer. Sun Y, Wang Y, Cheng X, Wu W, Liu Q, Chen X, Ren F. Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492 [Abstract] [Full Text] [Related]
5. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Hahn HS, Lee IH, Kim TJ, Lee KH, Shim JU, Kim JW, Lim KT. Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915 [Abstract] [Full Text] [Related]
6. Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma. Qian Y, Pollom EL, Nwachukwu C, Seiger K, von Eyben R, Folkins AK, Kidd EA. Gynecol Oncol; 2017 Oct; 147(1):24-29. PubMed ID: 28709703 [Abstract] [Full Text] [Related]
7. Risk factors for pelvic lymph node metastasis in endometrial cancer. Li Y, Cong P, Wang P, Peng C, Liu M, Sun G. Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773 [Abstract] [Full Text] [Related]
8. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, Roman LD. J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212 [Abstract] [Full Text] [Related]
9. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study. Unsal M, Kilic C, Cakir C, Kilic F, Ersak B, Karakas S, Tokgozoglu N, Varli B, Oktar O, Kimyon Comert G, Ozdemir IA, Boran N, Toptas T, Ureyen I, Korkmaz V, Taskin S, Moraloglu Tekin O, Ustun Y, Tasci T, Ortac F, Turan T. J Obstet Gynaecol; 2023 Dec; 43(1):2151355. PubMed ID: 36503383 [Abstract] [Full Text] [Related]
10. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment. Taşkın S, Şükür YE, Varlı B, Koyuncu K, Seval MM, Ateş C, Yüksel S, Güngör M, Ortaç F. Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064 [Abstract] [Full Text] [Related]
11. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma. Liu Y, Zhao LJ, Li MZ, Li MX, Wang JL, Wei LH. Chin Med J (Engl); 2015 Aug 05; 128(15):2084-9. PubMed ID: 26228223 [Abstract] [Full Text] [Related]
12. Analysis of Lymph Node Metastasis and Risk Factors in 975 Patients with FIGO 2009 Stage IA-IIA Cervical Cancer. Cao L, Kong W, Li J, Song D, Jin B, Liu T, Han C. Gynecol Obstet Invest; 2023 Aug 05; 88(1):30-36. PubMed ID: 36450266 [Abstract] [Full Text] [Related]
13. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S. Acta Obstet Gynecol Scand; 2002 Dec 05; 81(12):1144-51. PubMed ID: 12519111 [Abstract] [Full Text] [Related]
14. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection]. Ivanov I. Akush Ginekol (Sofiia); 2009 Dec 05; 48 Suppl 1():3-11. PubMed ID: 20387272 [Abstract] [Full Text] [Related]
15. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion. Mahdi H, Jernigan A, Nutter B, Michener C, Rose PG. J Gynecol Oncol; 2015 Jul 05; 26(3):208-13. PubMed ID: 25686395 [Abstract] [Full Text] [Related]
16. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer? Jaishankar S, Pifer PM, Bhargava R, Keller A, Musunuru HB, Patel AK, Sukumvanich P, Boisen M, Berger JL, Taylor S, Courtney-Brooks M, Olawaiye A, Lesnock J, Edwards R, Vargo JA, Beriwal S. Clin Oncol (R Coll Radiol); 2022 Jul 05; 34(7):452-458. PubMed ID: 35264314 [Abstract] [Full Text] [Related]
17. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study. Boyraz G, Salman MC, Basaran D, Ozgul N, Turan T, Turkmen O, Kimyon GC, Ozkan NT, Cagan M, Gungor T, Meydanli MM, Gungorduk K, Gulseren V, Sanci M, Yuce K. Int J Gynecol Cancer; 2017 Jan 05; 27(1):102-108. PubMed ID: 27668395 [Abstract] [Full Text] [Related]
18. Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI? Wenzel HHB, Van Kol KGG, Nijman HW, Lemmens VEPP, Van der Aa MA, Ebisch RMF, Bekkers RLM. Gynecol Oncol; 2020 Aug 05; 158(2):282-286. PubMed ID: 32381363 [Abstract] [Full Text] [Related]